Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Julphar
Medtronic
Mallinckrodt
Cerilliant
Deloitte
Cantor Fitzgerald
Covington
Dow

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for Patent: RE38919

« Back to Dashboard

Summary for Patent: RE38919
Title: Injectable microfoam containing a sclerosing agent
Abstract:Injectable microfoam for sclerotcraphy. The sclerotherapy of varices is based on the injection of liquid substances capable of suppressing them. The present invention relates to the preparation of sclerosing substances in the form of a microfoam. The microfoam is prepared with sclerosing agents, and is then injected in the vein to be treated, so that the microfoam displaces the blood contained in the vein and provides for the contact of the sclerosing agent with the vascular endothelium, with a predetermined known concentration and during a controllable time.
Inventor(s): Garrido; Juan Cabrera (Granada, ES), Garcia-Olmedo; Juan Cabrera (Granada, ES)
Assignee: BTG International Limited (London, GB)
Application Number:10/458,806
Patent Claim Types:
see list of patent claims
Formulation; Use;

Drugs Protected by US Patent RE38919

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent RE38919

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 179598 ➤ Try a Free Trial
Australia 7001294 ➤ Try a Free Trial
Germany 69418286 ➤ Try a Free Trial
Denmark 0656203 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Citi
McKinsey
UBS
Accenture
Teva
Colorcon
Boehringer Ingelheim
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.